Indivior PLC (INDV)
USD 9.44
(3.62%)
USD 9.44
(3.62%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.09 Billion USD | 26.53% |
| 2022 | 884.62 Million USD | 13.78% |
| 2021 | 777.48 Million USD | 12.73% |
| 2020 | 689.68 Million USD | -15.39% |
| 2019 | 815.15 Million USD | -15.08% |
| 2018 | 959.92 Million USD | -16.39% |
| 2017 | 1.14 Billion USD | 18.5% |
| 2016 | 968.88 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 299.6 Million USD | 5.97% |
| 2024 Q3 | 307 Million USD | 2.47% |
| 2024 Q1 | 282.73 Million USD | -5.96% |
| 2023 Q2 | 279.84 Million USD | 8.97% |
| 2023 FY | 1.11 Billion USD | 26.53% |
| 2023 Q4 | 300.65 Million USD | 15.1% |
| 2023 Q1 | 256.8 Million USD | 2.92% |
| 2023 Q3 | 261.19 Million USD | -6.66% |
| 2022 FY | 884.62 Million USD | 13.78% |
| 2022 Q4 | 249.52 Million USD | 13.3% |
| 2022 Q3 | 220.23 Million USD | 2.7% |
| 2022 Q2 | 214.43 Million USD | 5.78% |
| 2022 Q1 | 202.72 Million USD | -8.96% |
| 2021 FY | 777.48 Million USD | 12.73% |
| 2021 Q4 | 222.66 Million USD | 0.0% |
| 2020 FY | 689.68 Million USD | -15.39% |
| 2019 FY | 815.15 Million USD | -15.08% |
| 2018 FY | 959.92 Million USD | -16.39% |
| 2017 FY | 1.14 Billion USD | 18.5% |
| 2016 FY | 968.88 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 566.76 Million USD | -92.848% |
| Embecta Corp. | 1.12 Billion USD | 2.48% |
| ANI Pharmaceuticals, Inc. | 486.81 Million USD | -124.52% |
| Dynavax Technologies Corporation | 232.28 Million USD | -370.545% |
| Esperion Therapeutics, Inc. | 116.33 Million USD | -839.536% |
| Pacira BioSciences, Inc. | 674.97 Million USD | -61.931% |
| PainReform Ltd. | - USD | -Infinity% |
| Aquestive Therapeutics, Inc. | 50.58 Million USD | -2060.805% |
| Sunshine Biopharma, Inc. | 24.09 Million USD | -4436.627% |
| SCYNEXIS, Inc. | 140.14 Million USD | -679.929% |
| China SXT Pharmaceuticals, Inc. | 1.92 Million USD | -56576.261% |
| Cosmos Health Inc. | 53.37 Million USD | -1947.703% |
| Journey Medical Corporation | 79.18 Million USD | -1280.382% |
| Sunshine Biopharma, Inc. | 24.09 Million USD | -4436.627% |
| Safety Shot Inc | 202.67 Thousand USD | -539200.34% |
| Alpha Teknova, Inc. | 36.68 Million USD | -2879.501% |
| Intra-Cellular Therapies, Inc. | 464.37 Million USD | -135.373% |
| Bright Green Corporation | 401.49 Thousand USD | -272135.243% |
| Procaps Group, S.A. | 409.92 Million USD | -166.637% |
| Theratechnologies Inc. | 81.76 Million USD | -1236.774% |
| Harrow Health, Inc. | 130.19 Million USD | -739.523% |
| Sonoma Pharmaceuticals, Inc. | 12.73 Million USD | -8482.646% |
| Biofrontera Inc. | 34.07 Million USD | -3108.007% |
| DURECT Corporation | 8.54 Million USD | -12686.617% |
| Supernus Pharmaceuticals, Inc. | 607.52 Million USD | -79.911% |
| Cronos Group Inc. | 88.84 Million USD | -1130.289% |
| OptiNose, Inc. | 70.98 Million USD | -1439.719% |
| Ironwood Pharmaceuticals, Inc. | 442.73 Million USD | -146.875% |
| Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
| RedHill Biopharma Ltd. | 6.51 Million USD | -16681.375% |
| Organogenesis Holdings Inc. | 433.14 Million USD | -152.343% |
| Guardion Health Sciences, Inc. | 12.24 Million USD | -8823.505% |
| Cumberland Pharmaceuticals Inc. | 39.55 Million USD | -2663.415% |
| Radius Health, Inc. | 2.88 Billion USD | 62.078% |
| Universe Pharmaceuticals INC | 32.3 Million USD | -3282.986% |
| ProPhase Labs, Inc. | 44.38 Million USD | -2362.599% |
| Phibro Animal Health Corporation | 1.01 Billion USD | -7.401% |
| Procaps Group S.A. | 409.92 Million USD | -166.637% |
| Alvotech | 91.43 Million USD | -1095.398% |
| TherapeuticsMD, Inc. | 1.3 Million USD | -83847.773% |
| Viatris Inc. | 15.42 Billion USD | 92.915% |
| Rockwell Medical, Inc. | 83.61 Million USD | -1207.229% |
| Aytu BioPharma, Inc. | 81 Million USD | -1249.349% |
| SIGA Technologies, Inc. | 139.91 Million USD | -681.176% |
| Tilray Brands, Inc. | 788.94 Million USD | -38.54% |
| Lifecore Biomedical, Inc. | 128.26 Million USD | -752.169% |
| Shineco, Inc. | 9.8 Million USD | -11050.949% |
| PetIQ, Inc. | 1.1 Billion USD | 0.813% |
| Regencell Bioscience Holdings Limited | - USD | -Infinity% |
| Incannex Healthcare Limited | 12 Thousand USD | -9108233.333% |
| Neurocrine Biosciences, Inc. | 1.88 Billion USD | 42.08% |
| Alimera Sciences, Inc. | 80.75 Million USD | -1253.493% |
| Silver Spike Investment Corp. | 11.72 Million USD | -9224.242% |
| Assertio Holdings, Inc. | 152.06 Million USD | -618.753% |
| Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Petros Pharmaceuticals, Inc. | 5.82 Million USD | -18672.366% |
| Clever Leaves Holdings Inc. | 17.41 Million USD | -6175.478% |
| Cyclo Therapeutics, Inc. | 1.07 Million USD | -101441.706% |
| Avadel Pharmaceuticals plc | 27.96 Million USD | -3808.737% |
| Hempacco Co., Inc. | 4.04 Million USD | -26916.759% |
| Talphera, Inc. | 651 Thousand USD | -167795.545% |
| Alvotech | 91.43 Million USD | -1095.398% |
| Eagle Pharmaceuticals, Inc. | 316.61 Million USD | -245.22% |
| Lantheus Holdings, Inc. | 1.29 Billion USD | 15.691% |
| Currenc Group, Inc. | 53.25 Million USD | -1952.376% |
| Kamada Ltd. | 144.75 Million USD | -655.049% |
| Evoke Pharma, Inc. | 5.18 Million USD | -20997.82% |
| Flora Growth Corp. | 76.07 Million USD | -1336.816% |
| Cyclo Therapeutics, Inc. | 1.07 Million USD | -101441.706% |
| Evolus, Inc. | 202.08 Million USD | -440.862% |
| HUTCHMED (China) Limited | 837.99 Million USD | -30.43% |
| Amphastar Pharmaceuticals, Inc. | 644.39 Million USD | -69.616% |
| Akanda Corp. | 2.16 Million USD | -50500.634% |